213 related articles for article (PubMed ID: 29040913)
1. Generation of human erythroblast-derived iPSC line using episomal reprogramming system.
Varga E; Hansen M; Wüst T; von Lindern M; van den Akker E
Stem Cell Res; 2017 Dec; 25():30-33. PubMed ID: 29040913
[TBL] [Abstract][Full Text] [Related]
2. Generation of two induced pluripotent stem cell (iPSC) lines from human breast milk using episomal reprogramming system.
Tang C; Lu C; Ji X; Ma L; Zhou Q; Xiong M; Zhou W
Stem Cell Res; 2019 Aug; 39():101511. PubMed ID: 31404746
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of a human iPSC line SANi005-A containing the gray platelet associated heterozygous mutation p.Q287* in GFI1B.
Hansen M; Varga E; Wüst T; Mellink C; van der Kevie-Kersemaekers AM; Marneth AE; von Lindern M; van der Reijden B; van den Akker E
Stem Cell Res; 2017 Dec; 25():34-37. PubMed ID: 29055225
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
[TBL] [Abstract][Full Text] [Related]
5. Generation of a human control PBMC derived iPS cell line TUSMi001-A from a healthy male donor of Han Chinese genetic background.
Wang Y; Zhang Y; Zhang J; Lu J; Yang C; Zhao J; Li G; Liu Z; Lei Y
Stem Cell Res; 2017 Dec; 25():22-25. PubMed ID: 29035843
[TBL] [Abstract][Full Text] [Related]
6. Generation and characterization of human iPSC lines SANi001-A and SANi002-A from mobilized peripheral blood derived megakaryoblasts.
Hansen M; Varga E; Wüst T; Mellink C; van der Kevie-Kersemaekers AM; von Lindern M; van den Akker E
Stem Cell Res; 2017 Dec; 25():42-45. PubMed ID: 29055227
[TBL] [Abstract][Full Text] [Related]
7. Generation of the human erythroblast-derived iPSC line UBTi001-A.
Avdili A; Rohrhofer L; Auer M; Bernecker C; Schlenke P; Dorn I
Stem Cell Res; 2022 Oct; 64():102910. PubMed ID: 36103773
[TBL] [Abstract][Full Text] [Related]
8. Generation of a human induced pluripotent stem cell (iPSC) line from a 64year old male patient with multiple schwannoma.
Zhang S; Lv Z; Hu Y; Liu L; Gong W; Li Q; Wu H
Stem Cell Res; 2017 Mar; 19():49-51. PubMed ID: 28413006
[TBL] [Abstract][Full Text] [Related]
9. Development of human induced pluripotent stem cell (iPSC) line from a 60year old female patient with multiple schwannoma.
Zhang S; Lv Z; Liu Y; Li Q; Gong W; Liu L; Wu H
Stem Cell Res; 2017 Mar; 19():31-33. PubMed ID: 28413001
[TBL] [Abstract][Full Text] [Related]
10. Generation of a human induced pluripotent stem cell line (HMGUi002-A) from a healthy male individual.
Wang X; Malinowski AR; Beckenbauer J; Siehler J; Blöchinger A; Meitinger T; Häring HU; Staiger H; Burtscher I; Lickert H
Stem Cell Res; 2019 Aug; 39():101531. PubMed ID: 31419739
[TBL] [Abstract][Full Text] [Related]
11. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
[TBL] [Abstract][Full Text] [Related]
12. Generation of two induced pluripotent stem cells lines from Mucopolysaccharydosis IIIA patient: IMEDEAi004-A and IMEDEAi004-B.
Vallejo S; Fleischer A; Martín JM; Sánchez A; Palomino E; Bachiller D
Stem Cell Res; 2018 Oct; 32():110-114. PubMed ID: 30269021
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human induced pluripotent stem cell (iPSC) line from a 72year old male patient with later onset Alzheimer's disease.
Zhang S; Lv Z; Zhang S; Liu L; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():34-36. PubMed ID: 28413002
[TBL] [Abstract][Full Text] [Related]
14. Integration-free erythroblast-derived human induced pluripotent stem cells (iPSCs) from an individual with Ataxia-Telangiectasia (A-T).
Bhatt N; Ghosh R; Roy S; Gao Y; Armanios M; Cheng L; Franco S
Stem Cell Res; 2016 Sep; 17(2):205-207. PubMed ID: 27879207
[TBL] [Abstract][Full Text] [Related]
15. Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids.
Meraviglia V; Zanon A; Lavdas AA; Schwienbacher C; Silipigni R; Di Segni M; Chen HS; Pramstaller PP; Hicks AA; Rossini A
J Vis Exp; 2015 Jun; (100):e52885. PubMed ID: 26131963
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of a human iPSC line SANi007-A from a patient with a heterozygous dominant mutation in ELANE.
Aarts CEM; Varga E; Webbers S; Geissler J; von Lindern M; Kuijpers TW; van den Akker E
Stem Cell Res; 2021 Aug; 55():102440. PubMed ID: 34229202
[TBL] [Abstract][Full Text] [Related]
17. Generation of integration free human iPSC line SORMi002-A from neonatal foreskin fibroblasts.
Shivaraj A; Parveen S
Stem Cell Res; 2019 Oct; 40():101534. PubMed ID: 31454679
[TBL] [Abstract][Full Text] [Related]
18. Derivation and characterization of integration-free iPSC line ISRM-UM51 derived from SIX2-positive renal cells isolated from urine of an African male expressing the CYP2D6 *4/*17 variant which confers intermediate drug metabolizing activity.
Bohndorf M; Ncube A; Spitzhorn LS; Enczmann J; Wruck W; Adjaye J
Stem Cell Res; 2017 Dec; 25():18-21. PubMed ID: 29035842
[TBL] [Abstract][Full Text] [Related]
19. Efficient iPS cell generation from blood using episomes and HDAC inhibitors.
Hubbard JJ; Sullivan SK; Mills JA; Hayes BJ; Torok-Storb BJ; Ramakrishnan A
J Vis Exp; 2014 Oct; (92):e52009. PubMed ID: 25408260
[TBL] [Abstract][Full Text] [Related]
20. Derivation of human induced pluripotent stem cell line (HUSTi001-A) from a 40-year-old patient with idiopathic infertility.
Fang F; Li Z; Zhao Q; Ye Z; Zhao K; Gu X; Shen S; Reijo Pera RA; Xiong C
Stem Cell Res; 2018 Mar; 27():136-139. PubMed ID: 29414604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
